Searchable abstracts of presentations at key conferences in endocrinology

ea0090p766 | Thyroid | ECE2023

Is it necessary to elevate TSH for FDG-PET/CT imaging in differentiated thyroid carcinoma patients with TENIS Syndrome?

Şahin Ertan , Abidin Sayıner Zeynel , Elboğa Umut

Objective: We aimed to compare the effectiveness of F-18 fluorodeoxyglucose in positron emission computed tomography (FDG-PET/CT) findings under elevated TSH levels (eTSH) and suppressed TSH levels (sTSH) in differentiated thyroid carcinoma patients with TENIS syndrome (Thyroglobulin-elevated Negative Iodine Scintigraphy).Methods: A total of 23 patients with differentiated thyroid carcinoma (DTC) who undergone total thyroidectomy and 131I ablation therap...

ea0090p319 | Calcium and Bone | ECE2023

Unexpected first finding in primary hyperparathyroidism; peripheral giant cell granuloma in the mandibula

Koroğlu İpek , Abidin Sayıner Zeynel , Aytekin Alper , Akarsu Ersin

Aim and Introduction: Peripheral giant cell granulomas (PHDG) are uncommon exophytic lesions of the oral cavity that originate from the periosteum or periodontal membrane as a polypoid mass. Mandibular involvement is more common than maxillary involvement. Patients with primary hyperparathyroidism can infrequently exhibit PHDG in the early stages of the disease. We wanted to present our case who was examined for giant cell granuloma developing in the mandibula and was found to...

ea0090p488 | Thyroid | ECE2023

Evaluation of Factors Determining Iodine Refractoriness in Thyroid Carcinoma

Erten Aslı , Abidin Sayıner Zeynel , Koroğlu İpek , Oğuzkan Balcı Sibel , Akarsu Ersin

Introduction: Radioiodine-resistant thyroid carcinoma is an important milestone in the treatment and follow-up of thyroid cancers. The biological defects of iodine uptake in thyroid cancer cells should be well known. In this study, we aimed to evaluate the clinical and pathological features and SLC5A5 gene expression status of iodine-refractory papillary thyroid carcinoma patients. Material-Method: We studied SLC5A5 expression in 83 papillary thyroid car...

ea0090p530 | Thyroid | ECE2023

Coexistence of thyroid nodule and Graves’ disease: Is it a favorable factor for papillary thyroid cancer?

Yatkın Keleş Yağmur , Abidin Sayıner Zeynel , Koroğlu İpek , ozturk sadettin , Akarsu Ersin

Introduction: The incidence of papillary thyroid cancer (PTC) in the coexistence of GravesÂ’ disease (GD) and thyroid nodule is not known clearly, and the pathophysiology of PTC development in these patients is still unclear. Aim: The aim of our study is to compare the clinicopathological features of GD patients with thyroid nodule + PTC and patients with euthyroid and non auto-immune thyroid nodule + PTC and investigate the clinicopathological featu...